AbCellera Biologics Inc. (ABCL) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $390.05M | +28.1% |
| 2024 | $304.47M | -9.3% |
| 2023 | $335.78M | +9.1% |
| 2022 | $307.63M | +5.1% |
| 2021 | $292.84M | +67.3% |
| 2020 | $175.03M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $390.05M | +28.1% |
| 2024 | $304.47M | -9.3% |
| 2023 | $335.78M | +9.1% |
| 2022 | $307.63M | +5.1% |
| 2021 | $292.84M | +67.3% |
| 2020 | $175.03M | — |